
Overxon S 250mg/125mg Injection
Marketer
Medivaxia Pharma
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Overxon S 250mg/125mg Injection
Sulfamox-C 250mg/125mg Injection is a dual-action antibiotic used to combat diverse bacterial infections. Its mechanism inhibits microbial proliferation, thus controlling infection spread. Administration must be strictly under a doctor's guidance; all scheduled doses should be taken as prescribed, completing the entire course regardless of symptom improvement. Premature cessation may compromise its effectiveness. Commonly reported side effects include nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects warrant immediate medical attention. Seek immediate medical help for allergic reactions such as rash, itching, swelling, or breathing difficulties. Inform your physician of all current medications, including those for pre-existing conditions, before commencing treatment. Pregnant or lactating individuals should consult their doctor prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While it typically doesn't affect driving ability, avoid driving if drowsiness or dizziness occur. Adequate rest, a balanced diet, and sufficient hydration are recommended for optimal recovery. Your doctor might order blood tests and other diagnostic procedures to monitor the treatment's impact.
Uses of Overxon S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Overxon S 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Overxon S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Overxon S 250mg/125mg Injection:
This medication will be administered by your physician or their qualified assistant; self-medication is strictly prohibited.
How Overxon S 250mg/125mg Injection works:
Ceftriaxone and Sulbactam, combined as Overxon S 250mg/125mg Injection, offer a dual-action approach to bacterial infections. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to thrive. Sulbactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Alcohol consumption alongside Overxon S 250mg/125mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Overxon S, 250mg/125mg, is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nonetheless, clinical data from human subjects remain scarce.
Breast feedingCAUTION
Administering Overxon S 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
Administration of Overxon S 250mg/125mg Injection can induce drowsiness, blurred vision, and dizziness. Driving is inadvisable if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Overxon S 250mg/125mg Injection to individuals with impaired renal function. Seek medical advice from your physician.
LiverCAUTION
Patients with severe hepatic impairment should use Overxon S 250mg/125mg Injection cautiously, potentially requiring dosage modification. Physician consultation is advised. Dosage alteration for Overxon S 250mg/125mg Injection is unnecessary in individuals with mild or moderate liver dysfunction.
What if you forget to take Overxon S 250mg/125mg Injection :
Should you inadvertently omit a scheduled dose of Overxon S 250mg/125mg Injection, seek medical advice.
Facts to Know About Overxon S 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
